Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective
Background: Although opioid-induced bowel dysfunction is a well-known and frequent adverse event correlated with opioids, it is scarcely investigated in patients on opioid substitution treatment (OST) and no standard of care is currently available for this population. We aimed to explore the opinion...
Saved in:
Main Authors: | Fabio Lugoboni (Author), Genevieve Hall (Author), Vivek Banerji (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020) -
Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide
by: Katri Elina Clemens, et al.
Published: (2010) -
Opioid substitution therapy in resource-poor settings
by: Michelle Kermode, et al.
Published: (2011) -
Opioid substitution therapy in resource-poor settings
by: Michelle Kermode, et al. -
Clinical practice evaluation of opioids induced constipation management in patients with cancer: The EIO-50 project
by: Vicente Guillem, et al.
Published: (2019)